Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Rachel M Layman

15PUBLICATIONS
123CO-AUTHORS
Cancer cell biologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|May 04, 2026
Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution Experience.

|Mar 09, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano

|Jan 12, 2026
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.

Akshara Singareeka Raghavendra, Senthil Damodaran, Carlos H Barcenas

|Dec 17, 2025
ER degradation for ER<sup>+</sup>/HER2- advanced or metastatic breast cancer: a phase 1 trial.

Erika Hamilton, Rachel M Layman, David Cosgrove

|Jul 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Robert Wesolowski, Hope S Rugo, Jennifer M Specht

|May 13, 2025
Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers.

Mohd Mughees, Moises Tacam, Alex W Tan

Pageof 3

Frequent Collaborators

4 joint publications

Erika Hamilton

3 joint publications

Debu Tripathy

3 joint publications

Hope S Rugo

2 joint publications

Bora Lim

2 joint publications

Massimo Cristofanilli

2 joint publications

Adam Brufsky

2 joint publications

Naoto T Ueno

2 joint publications

Savitri Krishnamurthy

2 joint publications

Giuseppe Curigliano

2 joint publications

Angelica M Gutierrez Barrera

Frequent Collaborators

4 joint publications

Erika Hamilton

3 joint publications

Debu Tripathy

3 joint publications

Hope S Rugo

2 joint publications

Bora Lim

Top Related Videos

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on : Aug 12, 2015

8.8K
Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
10:38

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on : Dec 16, 2022

2.9K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

17.0K
See more related videos

Top Related Videos

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on : Aug 12, 2015

8.8K
Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
10:38

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on : Dec 16, 2022

2.9K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

17.0K
See more related videos